Skip to content

Clinical trials

Lung Diseases trials in the Netherlands with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Not applicable Country / region: Netherlands Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20182
20191
20211
20231
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Maastricht University Medical Center2
Consorcio Centro de Investigación Biomédica en Red (CIBER)1
General Practitioners Research Institute1
Leiden University Medical Center1
Philips Clinical & Medical Affairs Global1
Pulmair Medical, Inc.1
Ryme Medical, Inc.1
Umeå University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases9
Cardiovascular Diseases2
Dyspnea2
Pulmonary Disease, Chronic Obstructive2
Respiratory Tract Diseases2
Disease1
Embolism1
Embolism and Thrombosis1
Emphysema1
Lung Diseases, Obstructive1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.